TABLE 1 North America T-Cell therapy Market, 2019 - 2022, USD Million
TABLE 2 North America T-Cell therapy Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– T-Cell therapy Market
TABLE 4 Product Launches And Product Expansions– T-Cell therapy Market
TABLE 5 Acquisition and Mergers– T-Cell therapy Market
TABLE 6 Geographical Expansions – T-Cell therapy Market
TABLE 7 Trials and Approvals – T-Cell therapy Market
TABLE 8 North America T-Cell therapy Market by End User, 2019 - 2022, USD Million
TABLE 9 North America T-Cell therapy Market by End User, 2023 - 2030, USD Million
TABLE 10 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 11 North America Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 12 North America Cancer Treatment Centers Market by Country, 2019 - 2022, USD Million
TABLE 13 North America Cancer Treatment Centers Market by Country, 2023 - 2030, USD Million
TABLE 14 North America T-Cell therapy Market by Indication, 2019 - 2022, USD Million
TABLE 15 North America T-Cell therapy Market by Indication, 2023 - 2030, USD Million
TABLE 16 North America Lymphoma Market by Country, 2019 - 2022, USD Million
TABLE 17 North America Lymphoma Market by Country, 2023 - 2030, USD Million
TABLE 18 North America Acute Lymphocytic Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 19 North America Acute Lymphocytic Leukemia Market by Country, 2023 - 2030, USD Million
TABLE 20 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 21 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 22 North America T-Cell therapy Market by Therapy Type, 2019 - 2022, USD Million
TABLE 23 North America T-Cell therapy Market by Therapy Type, 2023 - 2030, USD Million
TABLE 24 North America CAR T-Cell Therapy Market by Country, 2019 - 2022, USD Million
TABLE 25 North America CAR T-Cell Therapy Market by Country, 2023 - 2030, USD Million
TABLE 26 North America T-Cell therapy Market by CAR T-Cell Therapy Type, 2019 - 2022, USD Million
TABLE 27 North America T-Cell therapy Market by CAR T-Cell Therapy Type, 2023 - 2030, USD Million
TABLE 28 North America Axicabtagene Ciloleucel Market by Country, 2019 - 2022, USD Million
TABLE 29 North America Axicabtagene Ciloleucel Market by Country, 2023 - 2030, USD Million
TABLE 30 North America Tisagenlecleucel Market by Country, 2019 - 2022, USD Million
TABLE 31 North America Tisagenlecleucel Market by Country, 2023 - 2030, USD Million
TABLE 32 North America Brexucabtagene Autoleucel Market by Country, 2019 - 2022, USD Million
TABLE 33 North America Brexucabtagene Autoleucel Market by Country, 2023 - 2030, USD Million
TABLE 34 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 35 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 36 North America T-Cell Receptor (TCR)-Based Market by Country, 2019 - 2022, USD Million
TABLE 37 North America T-Cell Receptor (TCR)-Based Market by Country, 2023 - 2030, USD Million
TABLE 38 North America T-Cell therapy Market by Country, 2019 - 2022, USD Million
TABLE 39 North America T-Cell therapy Market by Country, 2023 - 2030, USD Million
TABLE 40 US T-Cell therapy Market, 2019 - 2022, USD Million
TABLE 41 US T-Cell therapy Market, 2023 - 2030, USD Million
TABLE 42 US T-Cell therapy Market by End User, 2019 - 2022, USD Million
TABLE 43 US T-Cell therapy Market by End User, 2023 - 2030, USD Million
TABLE 44 US T-Cell therapy Market by Indication, 2019 - 2022, USD Million
TABLE 45 US T-Cell therapy Market by Indication, 2023 - 2030, USD Million
TABLE 46 US T-Cell therapy Market by Therapy Type, 2019 - 2022, USD Million
TABLE 47 US T-Cell therapy Market by Therapy Type, 2023 - 2030, USD Million
TABLE 48 US T-Cell therapy Market by CAR T-Cell Therapy Type, 2019 - 2022, USD Million
TABLE 49 US T-Cell therapy Market by CAR T-Cell Therapy Type, 2023 - 2030, USD Million
TABLE 50 Canada T-Cell therapy Market, 2019 - 2022, USD Million
TABLE 51 Canada T-Cell therapy Market, 2023 - 2030, USD Million
TABLE 52 Canada T-Cell therapy Market by End User, 2019 - 2022, USD Million
TABLE 53 Canada T-Cell therapy Market by End User, 2023 - 2030, USD Million
TABLE 54 Canada T-Cell therapy Market by Indication, 2019 - 2022, USD Million
TABLE 55 Canada T-Cell therapy Market by Indication, 2023 - 2030, USD Million
TABLE 56 Canada T-Cell therapy Market by Therapy Type, 2019 - 2022, USD Million
TABLE 57 Canada T-Cell therapy Market by Therapy Type, 2023 - 2030, USD Million
TABLE 58 Canada T-Cell therapy Market by CAR T-Cell Therapy Type, 2019 - 2022, USD Million
TABLE 59 Canada T-Cell therapy Market by CAR T-Cell Therapy Type, 2023 - 2030, USD Million
TABLE 60 Mexico T-Cell therapy Market, 2019 - 2022, USD Million
TABLE 61 Mexico T-Cell therapy Market, 2023 - 2030, USD Million
TABLE 62 Mexico T-Cell therapy Market by End User, 2019 - 2022, USD Million
TABLE 63 Mexico T-Cell therapy Market by End User, 2023 - 2030, USD Million
TABLE 64 Mexico T-Cell therapy Market by Indication, 2019 - 2022, USD Million
TABLE 65 Mexico T-Cell therapy Market by Indication, 2023 - 2030, USD Million
TABLE 66 Mexico T-Cell therapy Market by Therapy Type, 2019 - 2022, USD Million
TABLE 67 Mexico T-Cell therapy Market by Therapy Type, 2023 - 2030, USD Million
TABLE 68 Mexico T-Cell therapy Market by CAR T-Cell Therapy Type, 2019 - 2022, USD Million
TABLE 69 Mexico T-Cell therapy Market by CAR T-Cell Therapy Type, 2023 - 2030, USD Million
TABLE 70 Rest of North America T-Cell therapy Market, 2019 - 2022, USD Million
TABLE 71 Rest of North America T-Cell therapy Market, 2023 - 2030, USD Million
TABLE 72 Rest of North America T-Cell therapy Market by End User, 2019 - 2022, USD Million
TABLE 73 Rest of North America T-Cell therapy Market by End User, 2023 - 2030, USD Million
TABLE 74 Rest of North America T-Cell therapy Market by Indication, 2019 - 2022, USD Million
TABLE 75 Rest of North America T-Cell therapy Market by Indication, 2023 - 2030, USD Million
TABLE 76 Rest of North America T-Cell therapy Market by Therapy Type, 2019 - 2022, USD Million
TABLE 77 Rest of North America T-Cell therapy Market by Therapy Type, 2023 - 2030, USD Million
TABLE 78 Rest of North America T-Cell therapy Market by CAR T-Cell Therapy Type, 2019 - 2022, USD Million
TABLE 79 Rest of North America T-Cell therapy Market by CAR T-Cell Therapy Type, 2023 - 2030, USD Million
TABLE 80 key Information – Merck KGaA
TABLE 81 Key information –Johnson & Johnson
TABLE 82 Key information – AbbVie, Inc.
TABLE 83 Key Information – Gilead Sciences, Inc.
TABLE 84 Key Information – Amgen, Inc.
TABLE 85 Key Information – Novartis AG
TABLE 86 Key Information – Sorrento Therapeutics, Inc.
TABLE 87 Key Information – Bristol Myers Squibb Company
TABLE 88 Key Information – Pfizer, Inc.
TABLE 89 Key Information – Immunocore Holdings plc
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Sep – 2023, May) Leading Players
FIG 5 North America T-Cell therapy Market share by End User, 2022
FIG 6 North America T-Cell therapy Market share by End User, 2030
FIG 7 North America T-Cell therapy Market by End User, 2019 - 2030, USD Million
FIG 8 North America T-Cell therapy Market share by Indication, 2022
FIG 9 North America T-Cell therapy Market share by Indication, 2030
FIG 10 North America T-Cell therapy Market by Indication, 2019 - 2030, USD Million
FIG 11 North America T-Cell therapy Market share by Therapy Type, 2022
FIG 12 North America T-Cell therapy Market share by Therapy Type, 2030
FIG 13 North America T-Cell therapy Market by Therapy Type, 2019 - 2030, USD Million
FIG 14 North America T-Cell therapy Market share by Country, 2022
FIG 15 North America T-Cell therapy Market share by Country, 2030
FIG 16 North America T-Cell therapy Market by Country, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: Merck KGaA
FIG 18 Recent strategies and developments: Johnson & Johnson
FIG 19 SWOT analysis: Johnson & Johnson
FIG 20 Recent strategies and developments: Gilead Sciences, Inc.
FIG 21 Recent strategies and developments: Amgen, Inc.
FIG 22 Recent strategies and developments: Novartis AG
FIG 23 Recent strategies and developments: Sorrento Therapeutics, Inc.
FIG 24 Recent strategies and developments: Bristol Myers Squibb Company
FIG 25 Recent strategies and developments: Pfizer, Inc.
FIG 26 Recent strategies and developments: Immunocore Holdings plc
Unique Offerings 
